Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Forte Biosciences, Inc. - Common Stock (NQ:FBRX)

29.67 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Forte Biosciences, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Mr. David Gryska Appointed to Forte Biosciences Board of Directors
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Camac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital Raise
From Camac Partners, LLC
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. (NASDAQ:FBRX) Shareholder Notice: Investigation over Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 10/27/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Forte Biosciences, Inc. 
Via SBWire
News headline image
NASDAQ:FBRX Shareholder Notice: Investigation over Potential Securities Laws Violations by Forte Biosciences, Inc. ↗
San Diego, CA -- (SBWIRE) -- 09/17/2021 -- Forte Biosciences, Inc is under investigation concerning potential securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors With Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. to Review the Second Quarter 2021 Results and Expects to Announce Topline Data From Phase 2 Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis on Sept. 7
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. Announces First Quarter 2021 Results and Provides a General Business Update
From Forte Biosciences, Inc.
Via Business Wire
News headline image
Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update
From Forte Biosciences, Inc.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.